311 related articles for article (PubMed ID: 27544319)
1. Triglyceride Treatment in the Age of Cholesterol Reduction.
Agrawal N; Freitas Corradi P; Gumaste N; Goldberg IJ
Prog Cardiovasc Dis; 2016; 59(2):107-118. PubMed ID: 27544319
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.
Toth PP
Vasc Health Risk Manag; 2016; 12():171-83. PubMed ID: 27226718
[TBL] [Abstract][Full Text] [Related]
3. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Handelsman Y; Shapiro MD
Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia.
Maki KC; Guyton JR; Orringer CE; Hamilton-Craig I; Alexander DD; Davidson MH
J Clin Lipidol; 2016; 10(4):905-914. PubMed ID: 27578122
[TBL] [Abstract][Full Text] [Related]
5. Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease.
Miller M
Curr Opin Cardiol; 2024 Jul; 39(4):286-291. PubMed ID: 38482842
[TBL] [Abstract][Full Text] [Related]
6. Investigational drugs in development for hypertriglyceridemia: a coming-of-age story.
Rhainds D; Brodeur MR; Tardif JC
Expert Opin Investig Drugs; 2019 Dec; 28(12):1059-1079. PubMed ID: 31752565
[No Abstract] [Full Text] [Related]
7. Triglycerides and cardiovascular disease.
Nordestgaard BG; Varbo A
Lancet; 2014 Aug; 384(9943):626-635. PubMed ID: 25131982
[TBL] [Abstract][Full Text] [Related]
8. Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia.
Nurmohamed NS; Dallinga-Thie GM; Stroes ESG
Expert Rev Cardiovasc Ther; 2020 Jun; 18(6):355-361. PubMed ID: 32511037
[TBL] [Abstract][Full Text] [Related]
9. Fibrates, Hypertriglyceridemia, and CVD Risk: Where Do We Stand After the PROMINENT Trial for Triglyceride Lowering?
Chukwurah MI; Miller M
Curr Cardiol Rep; 2023 Sep; 25(9):987-992. PubMed ID: 37505399
[TBL] [Abstract][Full Text] [Related]
10. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
[TBL] [Abstract][Full Text] [Related]
11. Hypertriglyceridaemia and risk of coronary artery disease.
Reiner Ž
Nat Rev Cardiol; 2017 Jul; 14(7):401-411. PubMed ID: 28300080
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessment.
Wieczorek E; Ćwiklińska A; Jankowski M
Clin Chem Lab Med; 2022 Jul; 60(8):1145-1159. PubMed ID: 35687325
[TBL] [Abstract][Full Text] [Related]
13. Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers.
Sun CJ; Brisson D; Gaudet D; Ooi TC
J Clin Lipidol; 2020; 14(6):825-836. PubMed ID: 33032940
[TBL] [Abstract][Full Text] [Related]
14. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis.
Hernandez P; Passi N; Modarressi T; Kulkarni V; Soni M; Burke F; Bajaj A; Soffer D
Curr Atheroscler Rep; 2021 Sep; 23(11):72. PubMed ID: 34515873
[TBL] [Abstract][Full Text] [Related]
15. Management of hypertriglyceridemia for prevention of atherosclerotic cardiovascular disease.
Brinton EA
Cardiol Clin; 2015 May; 33(2):309-23. PubMed ID: 25939302
[TBL] [Abstract][Full Text] [Related]
16. Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention.
Quispe R; Sweeney T; Varma B; Agarwala A; Michos ED
Curr Atheroscler Rep; 2022 Oct; 24(10):767-778. PubMed ID: 35895246
[TBL] [Abstract][Full Text] [Related]
17. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
Rosenson RS; Davidson MH; Hirsh BJ; Kathiresan S; Gaudet D
J Am Coll Cardiol; 2014 Dec; 64(23):2525-40. PubMed ID: 25500239
[TBL] [Abstract][Full Text] [Related]
18. Triglyceride-Rich Lipoproteins.
Kockx M; Kritharides L
Cardiol Clin; 2018 May; 36(2):265-275. PubMed ID: 29609756
[TBL] [Abstract][Full Text] [Related]
19. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors.
Spagnuolo CM; Hegele RA
Expert Opin Pharmacother; 2023 Jun; 24(9):1013-1020. PubMed ID: 37114828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
